Ali Duarte-García, MD; Eric L. Matteson, MD, MPH; Nilay D. Shah, PhD
Financial Support: Dr. Duarte-García is supported by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, which receives no industry funding.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3513.
Corresponding Author: Ali Duarte-García, MD, Division of Rheumatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; e-mail, email@example.com.
Current Author Addresses: Drs. Duarte-García and Matteson: Division of Rheumatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Dr. Shah: Division of Health Care Policy and Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Author Contributions: Conception and design: A. Duarte-García, E.L. Matteson.
Analysis and interpretation of the data: E.L. Matteson, N.D. Shah.
Drafting of the article: A. Duarte-García, E.L. Matteson.
Critical revision of the article for important intellectual content: A. Duarte-García, E.L. Matteson, N.D. Shah.
Final approval of the article: A. Duarte-García, E.L. Matteson, N.D. Shah.
Administrative, technical, or logistic support: N.D. Shah.
Duarte-García A, Matteson EL, Shah ND. Older Drugs With Limited Trial Evidence: Are They Worth the Expense? The Case of Repository Corticotropin Marketed as H.P. Acthar Gel. Ann Intern Med. 2019;170:791–792. [Epub ahead of print 28 May 2019]. doi: 10.7326/M18-3513
Download citation file:
Published: Ann Intern Med. 2019;170(11):791-792.
Published at www.annals.org on 28 May 2019
Endocrine and Metabolism.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use